News Release: January 15, 2021
Budget Also Invests In Public Health, Public Safety, Infrastructure And Wildfire PreventionContinue reading
Category Archives: AZBio News
Record Number of Startups Currently Enrolled in the University of Arizona Center for Innovation
Rapid growth seen from entrepreneurs who want to make a significant difference in the local and global communities through innovation.
TUCSON, Ariz. (January 15, 2021) — The University of Arizona Center for Innovation (UACI) is pleased to announce that more than 40 startups, a record number, are enrolled in the incubation program. Passionate entrepreneurs from across the nation have flocked to UACI. Each one of the 40+ tech and science-based startups are developing solutions for real-world problems and have a strong desire to make a significant difference in the local and global communities through innovation.
C-Path Announces SHIP-MD 2021 Virtual Workshop
Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development
TUCSON, Ariz., January 14, 2021 — The Critical Path Institute (C-Path) in collaboration with the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH), AdvaMed, the American Academy of Pediatrics (AAP) and multiple pediatric health system leaders, is proud to announce the System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop to be held on February 9-11, 2021. The workshop will focus on the acceleration of medical device development for the unique needs of children.
FDA Releases Final Rule on the Safer Technologies Program for Medical Devices (STeP)
The FDA is introducing a new, voluntary program for certain medical devices and device-led combination products1 that are reasonably expected to significantly improve the safety of currently available treatments or diagnostics that target an underlying disease or condition associated with morbidities and mortalities less serious than those eligible for the Breakthrough Devices Program.
Learn about the Safer Technologies Program for Medical Devices (STeP) program
Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicine
January 13, 2021 — Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.
BIO Announces New Interactive Opportunities to Showcase Your Company
The new Innovation Stage is a must-attend forum provides the best opportunity for leading global innovators, regional economic development groups, patient groups and more to showcase new global biotech insights, build global connections and identify business prospects as a primer to partnering ahead of BIO Digital Week.
UArizona Researchers Develop New Tools to Predict Premature Birth, Neonatal Morbidity
Researchers from the University of Arizona College of Medicine – Phoenix and Indiana University School of Medicine have developed a new diagnostic tool to better predict the likelihood of premature birth and neonatal morbidity in the early stages of pregnancy, which may increase care and outcomes for both baby and mother.
Continue reading
Dr. Laurence Hurley Inducted into the National Academy of Inventors
University of Arizona Health Sciences faculty member Laurence Hurley, PhD, professor emeritus in the College of Pharmacy, has been elected as fellow of the National Academy of Inventors (NAI). The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.Continue reading
Life365 Recognized for Innovation
SCOTTSDALE, AZ — January 12, 2021 — Life365 has been named a winner in the 2021 BIG Innovation Awards presented by the Business Intelligence Group. Continue reading
CMS Releases Final Rule on Medicare Coverage of Innovative Technology (MCIT)
The CMS rule the establishes a new coverage pathway – MCIT – for breakthrough medical technologies.